FDA Still Testing Bausch & Lomb Solution Plants
WASHINGTON (Reuters) – The Food and Drug Administration said on Friday it was continuing inspections of Bausch & Lomb facilities where the company makes a contact lens solution that was recalled after reports of serious eye infections in some users.
“Extensive microbiological testing is being conducted and may take up to one month to fully analyze,” the FDA said in a statement posted on its Web site at http://www.fda.gov/oc/opacom/hottopics/contacts.html.
Last week, Bausch & Lomb stopped shipping the solution, called ReNu with MoistureLoc, and urged retailers to pull it from their shelves while officials investigated whether it contributed to cases of fungal keratitis. The infection can cause blindness if not treated.
The FDA said it was inspecting Bausch & Lomb facilities in Greenville, South Carolina, with the federal Centers for Disease Control and Prevention.
Shares of the Rochester, New York-based company were down 18 cents at $46.82 in afternoon trading on the New York Stock Exchange.